Yongfeng Chen

Title: Yongfeng Chen - Innovator in Antibody Development

Introduction

Yongfeng Chen is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific proteins involved in coagulation.

Latest Patents

Yongfeng Chen holds a patent for an "Antibody against factor XIa in activated form of coagulant factor XI, preparation method therefor and use thereof." This innovative antibody is designed to specifically bind to FXIa, while not affecting FXI. The invention has the potential to inhibit the endogenous pathway of human coagulation without impacting the exogenous pathway. This characteristic can significantly reduce the formation of arteriovenous shunt thrombosis without increasing bleeding time or volume, making it a promising candidate for an antithrombotic drug. He has 1 patent to his name.

Career Highlights

Yongfeng Chen is currently associated with Mab-legend Biotech Co., Ltd., where he continues to advance his research in antibody development. His work is pivotal in the ongoing efforts to create effective treatments for coagulation disorders.

Collaborations

Yongfeng collaborates with notable colleagues such as Shaoxiong Wang and Juehua Xu, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Yongfeng Chen's work in antibody development represents a significant advancement in the field of biotechnology. His innovative approaches have the potential to lead to new therapeutic options for patients with coagulation issues.